New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 31, 2013
14:50 EDTAMRS, GEVO, KIOR, SZYM, REX, BIOF, PEIX, ANDE, GPRE, ADMEPA proposes 2013 renewable fuel standards
The U.S. Environmental Protection Agency is proposing the 2013 percentage standards for four fuel categories that are part of the agency’s Renewable Fuel Standard program. The proposal will be open for a 45-day public comment period and EPA will consider feedback from a range of stakeholders before the proposal is finalized. The proposed 2013 overall volumes and standards include total renewable fuels at 16.55B gallons, including biomass-based diesel at 1.28B gallons, advanced biofuels at 2.75B gallons and cellulosic biofuels at 14M gallons. The Fly notes companies whose business involves ethanol for use in transportation include Archer Daniels (ADM), Andersons (ANDE), Biofuel Energy (BIOF), Green Plains (GPRE), Pacific Ethanol (PEIX) and REX American Resources (REX). Other companies involved in biofuel and renewable fuels include Solazyme (SZYM), Gevo (GEVO), Amyris (AMRS) and KiOR (KIOR). Reference Link
News For ADM;ANDE;BIOF;GPRE;PEIX;REX;SZYM;GEVO;AMRS;KIOR From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
March 4, 2015
18:37 EDTPEIXOn The Fly: After Hours Movers
UP AFTER EARNINGS: Roundy's (RNDY), up 12.7%... Pacific Ethanol (PEIX), up 11.5%... Miller Industries (MLR), 6.9%. ALSO HIGHER: Pharmacyclics (PCYC), up 2.8% after speculation of acquisition by Johnson & Johnson (JNJ). Johnson & Johnson is up marginally. DOWN AFTER EARNINGS: Semtech (SMTC), down 5.3%... Callon Petroleum (CPE), down 1.3%. ALSO LOWER: Vanda Pharmaceuticals (VNDA), down 7% following results from tradipitant Phase II study... Encana (ECA), down 4.2% after announcing C$1.25B bought deal offering... Apollo Commercial (ARI), down 2.9% after filing to sell 10M shares of common stock... Neustar (NSR), down 2.7% after making statement on LNPA vendor selection.
16:11 EDTPEIXPacific Ethanol reports Q4 adjusted EPS 41c, consensus 15c
Subscribe for More Information
March 3, 2015
08:11 EDTAMRSAmyris announces partnership with Genome Compiler
Amyris and Genome Compiler, a synthetic biology platform company, have entered into a collaboration agreement to integrate Amyris's automated lab services with Genome Compiler's online design tools and e-commerce platform to enable users to design and order DNA or other biological products seamlessly. This integration will provide a comprehensive solution from design to delivery of first-of-its-kind integrated DNA design and construction service, which promises to be more automated, less expensive, and more sophisticated than current offerings. Customers will benefit from Genome Compiler's software tools and Amyris's rich libraries of verified genetic parts, DNA construction and editing methods. This joint project is funded in part by a grant from the Binational Industrial Research and Development Foundation, a U.S.-Israeli partnership between private sectors to expand private high-tech industries.
07:33 EDTAMRSMorgan Stanley to hold a conference
Subscribe for More Information
March 2, 2015
18:04 EDTSZYMSolazyme files to delay Form 10-K
The company expects to file the subject report on Form 10-K for the fiscal year ended December 31, 2014 on or before the fifteenth calendar day following the due date. The Form 10-K could not be filed by the date required due to unanticipated delays in assembling all information required to complete the audited financial statements that are required to be included in the Form 10-K.
February 26, 2015
16:23 EDTSZYMSolazyme reports Q4 EPS (57c), consensus (47c)
Reports Q4 revenue $14.5M, consensus $17.7M.
February 25, 2015
05:11 EDTSZYMSolazyme receives FDA GRAS No Questions Letter for high oleic algae oil
Solazyme announced that the FDA has issued a favorable response to Solazyme’s notification which concludes that high-oleic algae oil is Generally Recognized as Safe as an ingredient in food products under the intended conditions of use. This No Questions letter will further pave the way for mainstream adoption of superior quality oleic algae oil with unprecedented functional, performance and nutritional benefits, enabling the creation of new products that meet consumer demand for healthy, sustainable ingredients. Solazyme has also received FDA No Questions letters for the whole food ingredient products currently offered within the AlgaVia portfolio, including Whole Algal Protein and Whole Algal Flour.
February 24, 2015
16:10 EDTAMRSAmyris reports Q4 adjusted EPS (40c), consensus (29c)
Subscribe for More Information
February 23, 2015
11:29 EDTADMEU investigates Cargill's proposed acquisition of ADM's chocolate business
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use